Hongyuan Sun

Hongyuan (Stanley) Sun, PhD, CFA, is an accomplished professional in business development and licensing within the biotechnology sector. Currently serving as the Associate Director of BD & Licensing at Legend Biotech since May 2023, Hongyuan specializes in cell therapy asset in-licensing. Prior roles include Associate Director and Senior Manager of BD & Licensing at HARBOUR BIOMED, where responsibilities encompassed asset licensing and corporate development, and Senior Manager of BD & Licensing at WuXi Biologics, focused on licensing biological therapeutics. Earlier experience as an Investment Manager at Sangel Capital involved overseeing investments in biotech startups. Hongyuan holds a PhD in Cell Biology from the University of Chinese Academy of Sciences and a Bachelor's degree in Biotechnology from Fudan University.